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ABSTRACT Mutation of the inositol 5-phosphatase OCRL1 causes Lowe syndrome and Dent-
2 disease. Loss of OCRL1 function perturbs several cellular processes, including membrane 
traffic, but the underlying mechanisms remain poorly defined. Here we show that OCRL1 is 
part of the membrane-trafficking machinery operating at the trans-Golgi network (TGN)/en-
dosome interface. OCRL1 interacts via IPIP27A with the F-BAR protein pacsin 2. OCRL1 and 
IPIP27A localize to mannose 6-phosphate receptor (MPR)–containing trafficking intermedi-
ates, and loss of either protein leads to defective MPR carrier biogenesis at the TGN and 
endosomes. OCRL1 5-phosphatase activity, which is membrane curvature sensitive, is stimu-
lated by IPIP27A-mediated engagement of OCRL1 with pacsin 2 and promotes scission of 
MPR-containing carriers. Our data indicate a role for OCRL1, via IPIP27A, in regulating the 
formation of pacsin 2–dependent trafficking intermediates and reveal a mechanism for cou-
pling PtdIns(4,5)P2 hydrolysis with carrier biogenesis on endomembranes.
INTRODUCTION
Phosphoinositide lipids, of which there are seven species, are im-
portant modulators of a wide variety of cellular functions, typically 
acting to recruit and/or sterically activate downstream effector pro-
teins at distinct cellular locations (Di Paolo and De Camilli, 2006; 
Balla, 2013). For example, phosphatidylinositol 4,5-bisphosphate 
(PtdIns(4,5)P2) is abundant at the plasma membrane, where it is a 
key regulator of endocytosis and actin dynamics. The abundance 
and spatial distribution of phosphoinositides is tightly controlled by 
phosphoinositide kinases and phosphatases, which also are highly 
regulated (Sasaki et al., 2009). The importance of such regulation is 
indicated by the fact that numerous human diseases can be attrib-
uted to defective phosphoinositide kinase or phosphatase function 
and the resultant dysregulation of phosphoinositide metabolism 
that occurs in such cases (McCrea and De Camilli, 2009; Billcliff and 
Lowe, 2014).
Mutation of the inositol 5-phosphatase OCRL1, whose preferred 
substrate is PtdIns(4,5)P2, causes two disorders in humans, namely 
Lowe syndrome and Dent-2 disease (Attree et al., 1992; Hoopes 
et al., 2005). OCRL1 has been localized to a number of cellular com-
partments, including clathrin-coated pits, early endosomes, and the 
trans-Golgi network (TGN; Pirruccello and De Camilli, 2012; Mehta 
et al., 2014). Targeting of OCRL1 depends on binding to Rab 
GTPases (Hyvola et al., 2006; Hou et al., 2011), with additional part-
ners contributing to the fidelity of membrane recruitment. OCRL1 
has been implicated in a number of cellular processes, including 
endocytic trafficking (Choudhury et al., 2005; Erdmann et al., 2007; 
Vicinanza et al., 2008; van Rahden et al., 2012; Nandez et al., 2014), 
cytokinesis (Ben El Kadhi et al., 2011; Dambournet et al., 2011), cil-
iogenesis (Coon et al., 2012; Luo et al., 2012; Rbaibi et al., 2012), 
cell junction formation (Grieve et al., 2011), and cell migration (Coon 
et al., 2009). How OCRL dysfunction can affect so many processes is 
unclear (Mehta et al., 2014). In some cases, OCRL1 appears to act 
directly—for example in clathrin vesicle formation at the plasma 
membrane. However, whether this is true for most of the cellular 
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is neuronal specific, and pacsin 3, which has a more restricted tissue 
expression than the ubiquitous pacsin 2 (Kessels and Qualmann, 
2004). IPIP27A is able to interact with all pacsins (Supplemental 
Figure S2A), suggesting that it likely participates more widely in pac-
sin function. IPIP27 and pacsin 2 can be coimmunoprecipitated from 
cell extracts, consistent with interaction in vivo (Figure 1E).
To determine whether IPIP27A can physically link pacsin 2 to 
OCRL1, we performed in vitro binding experiments with recombi-
nant proteins. When GST-IPIP27A C-terminus was coupled to beads 
and incubated with purified OCRL1 in the presence of increasing 
amounts of maltose binding protein (MBP)–tagged pacsin 2 SH3 
domain, both ligands simultaneously bound to IPIP27A, with pacsin 
2 binding increasing in proportion to the amount added (Figure 1F). 
This is consistent with the binding of pacsin 2 and OCRL1 to distinct 
sites in IPIP27A. Of interest, OCRL1 contains a PxxP motif in the N-
terminal region (175REPPPPP181) that was previously shown to bind 
SNX9 (Nandez et al., 2014), raising the possibility of OCRL1 binding 
directly to the SH3 domain of pacsin 2. However, we could rule this 
out by showing that OCRL1 is unable to bind pacsin 2 in the ab-
sence of IPIP27A (Supplemental Figure S2B). Taken together, these 
results indicate that IPIP27A can physically link pacsin 2 to OCRL1 
through distinct binding sites in its C-terminal region.
Pacsin 2 colocalizes with OCRL1 and IPIP27A at the TGN 
and early endosomes
Previous work has shown that although pacsin 2 is predominantly 
diffuse in the cytoplasm, pools of the protein reside at various 
compartments, including the TGN and endosomes (Kessels et al., 
2006; de Kreuk et al., 2011; 2012; Giridharan et al., 2013). We 
therefore examined whether pacsin 2 colocalizes with OCRL1 and 
IPIP27A on these compartments. For this purpose, we expressed 
tagged versions of the proteins at low levels in COS-7 cells and 
visualized them by fluorescence microscopy. As shown in Figure 
2A, we confirmed colocalization of GFP–pacsin 2 with mCherry-
OCRL1 and Myc-IPIP27A at both early/recycling endosomes, 
marked with EEA1 and transferrin receptor, and the TGN, marked 
with golgin-97. Endogenous pacsin 2, detected with a custom-
made antibody, was similarly localized (Figure 2B). Quantification 
revealed that 69% (n = 470) of OCRL1-positive compartments 
contained pacsin 2, with a high degree of colocalization between 
OCRL1 and pacsin 2, indicated by a Pearson’s r = 0.78 ± 0.10 (SD, 
n = 64). Of interest, when we expressed the D40K mutant of pac-
sin 2, which has increased membrane binding and tubulation 
properties (Shimada et al., 2010), we observed increased recruit-
ment of OCRL1 onto pacsin 2–positive cytoplasmic puncta and 
tubules in the presence but not absence of ectopically expressed 
IPIP27A (Figure 2C). Recruitment was abolished using IPIP27A 
mutants unable to bind OCRL1 (F224A) or pacsin 2 (RR > AA), 
confirming that interactions with both proteins are required for 
the observed recruitment (Figure 2C). This result indicates that 
IPIP27A can physically link OCRL1 to membrane-associated pac-
sin 2 in vivo, consistent with the formation of a tripartite complex 
in cells.
OCRL1 and IPIP27A are present on TGN and endosome-
derived cation-independent MPR trafficking intermediates
The ability of IPIP27A to physically link OCRL1 with pacsin 2, a pro-
tein involved in the biogenesis of trafficking intermediates, implies 
a direct role for OCRL1 in the carrier formation process. A recent 
study showed that OCRL1 functions at a late stage of clathrin-
coated vesicle formation at the plasma membrane (Nandez et al., 
2014). However, it remains to be determined whether OCRL1 or 
defects observed upon OCRL1 loss or instead reflects a more 
general role for OCRL1 in maintaining PtdIns(4,5)P2 homeostasis is 
not clear.
The PH domain proteins IPIP27A and B (also known as Ses1 and 
2) have been identified as novel interactors of OCRL1 (Swan et al., 
2010; Noakes et al., 2011). We previously showed that the IPIP27 
proteins are required for efficient endocytic recycling (Noakes et al., 
2011). Here we demonstrate that IPIP27A can physically link OCRL1 
to the F-BAR–domain protein, protein kinase C and casein kinase 2 
substrate in neurons (pacsin) 2 (also known as syndapin 2; Kessels 
and Qualmann, 2004). Pacsin 2 is part of the trafficking machinery, 
able to sculpt membranes through its F-BAR domain and interac-
tions with the actin cytoskeleton, as well as coordinate carrier mor-
phogenesis with membrane scission through interactions with dyna-
min and/or eps15 homology domain–containing (EHD) proteins 
(Kessels and Qualmann, 2004; Kostan et al., 2014; Quan and Robin-
son, 2014). Our findings indicate that OCRL1 and IPIP27A function 
together with pacsin 2 to regulate formation of trafficking intermedi-
ates containing the mannose 6-phosphate receptor (MPR) at the 
TGN and endosomes and suggest an important role for PtdIns(4,5)
P2 hydrolysis in regulating this process.
RESULTS
IPIP27A links pacsin 2 to OCRL1
We previously proposed that the IPIP27 proteins act as adaptors, 
linking OCRL1 to machinery involved in endocytic trafficking (Noakes 
et al., 2011). To explore this possibility, we performed pull-down ex-
periments using a HeLa cell extract and C-terminal fragments of 
IPIP27A and IPIP27B as bait, with bound proteins identified by mass 
spectrometry. Using this approach, we identified the actin-associ-
ated SH3 domain proteins myosin 1E, pacsin 2, and CD2AP as part-
ners for IPIP27A but not IPIP27B (Supplemental Figure S1). We de-
cided to focus on pacsin 2 for further study, which has an F-BAR 
domain (Figure 1A), due to its role in biogenesis of trafficking inter-
mediates (Kessels and Qualmann, 2004; Kostan et al., 2014; Quan 
and Robinson, 2014). Binding of pacsin 2 to IPIP27A was confirmed 
by Western blotting (Figure 1B, bottom). Note that pacsin 2 binds 
only to IPIP27A, whereas OCRL1 binds to both IPIPs, as reported 
previously (Swan et al., 2010; Noakes et al., 2011; Supplemental 
Figure S1 and Figure 1B, top). Similar results were obtained using 
green fluorescent protein (GFP)–tagged pacsin 2 transiently ex-
pressed in HeLa cells (Figure 1C). IPIP27A has several PxxP motifs in 
its C-terminal region that are potential SH3 domain–binding sites 
(Figure 1A). We therefore reasoned that IPIP27A would bind to the 
SH3 domain of pacsin 2. This was the case, because the SH3 domain 
of pacsin 2 was sufficient for IPIP27A binding (Figure 1D, rightmost 
column), and binding was abolished by mutation of a conserved 
proline residue in the peptide-binding groove of the SH3 domain 
(P478L) (Figure 1, A and C, bottom). No binding of IPIP27A to the 
SH3 domain proteins cortactin, signal-transducing adapter mole-
cule, and sorting nexin 9 (SNX9), which was recently shown to bind 
directly to OCRL1 (Nandez et al., 2014), was observed, indicating 
that IPIP27A binding to SH3 domain proteins is selective (Figure 1C).
Mutation of the various PxxP motifs in IPIP27A revealed that a 
203PPPxPPRR210 motif located upstream of the 5-phosphatase bind-
ing F&H motif is the major pacsin 2 binding site (Figure 1, A and D). 
Mutation of the Pro residues or the pair of C-terminal Arg residues in 
this motif almost completely abolished pacsin 2 binding, whereas 
mutation of another putative PxxP motif in the C-terminal region of 
IPIP27A (215PHGP218) had no effect on binding (Figure 1D, bottom). 
Given the similarity between the SH3 domains of the different human 
pacsins, we next tested whether IPIP27A can bind to pacsin 1, which 
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FIGURE 1: Interaction of IPIP27A with pacsin 2. (A) Schematic view of IPIP27A and pacsin 2. IPIP27A contains an 
N-terminal PH domain (red), a coiled-coil region (gray), a proline-rich region (navy blue), and a C-terminal F&H motif that 
mediates binding to OCRL1 and INPP5B (yellow). Vertical bars correspond to putative PxxP motifs. The 
203PPPxPPRR210 motif is highlighted. Pacsin 2 has an N-terminal F-BAR domain (light blue) and a C-terminal SH3 
domain (green). The green vertical bars correspond to NPF motifs that mediate binding to EHD proteins. (B) Beads 
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IPIP27A functions with pacsin 2 in CIMPR carrier biogenesis
We next investigated whether IPIP27A, which links OCRL1 to pacsin 
2, is required for the formation of CIMPR-containing trafficking inter-
mediates. IPIP27A was depleted using RNA interference (RNAi; 
Figure 4A), and CIMPR trafficking was analyzed by time-lapse mi-
croscopy. As expected, in control cells, GFP-CIMPR was abundant in 
the perinuclear TGN and more peripheral endosomes and dynamic 
carriers moving between these compartments (Figure 4, B and E). 
The budding of vesicular and short tubular carriers was frequently 
observed, as previously reported (Waguri et al., 2003; Anitei et al., 
2010; Temkin et al., 2011; Figure 4E and Supplemental Videos S6 
and S7). Strikingly, in IPIP27A-depleted cells, the detachment of 
GFP-CIMPR carriers was impaired, and they appeared as elongated 
tubules emanating from both the perinuclear TGN and peripheral 
endosomes (Figure 4, B and E, and Supplemental Videos S8–S10). 
Both the number of CIMPR tubules and their length were dramati-
cally increased upon IPIP27A depletion (Figure 4, C and D). Some of 
the tubules were long-lived, although most were dynamic and grew 
or collapsed during the course of the movies (Figure 4E and Supple-
mental Videos S8–S10). The impaired detachment of the CIMPR 
tubules from the donor membrane is suggestive of a membrane 
scission defect. The phenotype was observed with two independent 
small interfering RNAs (siRNAs) and also to a lesser extent in a ge-
nome-edited HeLa line lacking IPIP27A, confirming its specificity 
(Supplemental Figure S5, A and B). Depletion of IPIP27A also elic-
ited a similar phenotype in COS-7 cells (Supplemental Figure S5C).
To determine whether pacsin 2 is required for generation of the 
CIMPR tubules in IPIP27A-depleted cells, we depleted it alone or 
together with IPIP27A and imaged GFP-CIMPR dynamics in live 
cells. As shown in Figure 4, F–H, pacsin 2 depletion caused a marked 
reduction in both the abundance and length of GFP-CIMPR tubules, 
indicating a requirement for pacsin 2 in forming these structures. To 
confirm the specificity of the tubulation phenotype, we examined 
whether depletion of the endosomal BAR domain protein SNX1 
would cause a similar effect. As shown in Figure 4I, depleting SNX1 
did not affect the CIMPR tubulation elicited by IPIP27A depletion. 
Neither tubule abundance nor tubule length was affected by SNX1 
depletion (Figure 4, J and K). Conversely, depletion of either IPIP27A 
or pacsin 2 had no effect on SNX1 carrier formation (Supplemental 
Figure S6). Taken together, these results indicate aberrant formation 
of pacsin 2–dependent CIMPR carriers upon loss of IPIP27A and that 
these carriers are functionally distinct from those containing SNX1.
We next sought to confirm the functional importance of interac-
tions between pacsin 2, IPIP27A, and OCRL1. Unfortunately we 
were unable to rescue the tubulation phenotype by reexpression of 
wild-type IPIP27A, precluding rescue experiments with binding mu-
tants. We attribute this to an inability to achieve uniform expression 
of IPIP27A at endogenous or close to endogenous levels. We there-
fore resorted to an overexpression strategy. We previously showed 
that expression of OCRL1 lacking the catalytic domain (OCRL1∆PIP2) 
IPIP27A functions in biogenesis of trafficking intermediates at 
endomembranes. MPR trafficking at the TGN/endosome interface 
is sensitive to loss of either protein, raising the possibility that they 
may function in biogenesis of cation-independent MPR (CIMPR)–
containing carriers at the TGN or endosomes (Choudhury et al., 
2005; Hyvola et al., 2006; Cui et al., 2010; Noakes et al., 2011; 
Vicinanza et al., 2011; van Rahden et al., 2012). We therefore exam-
ined whether OCRL1 or IPIP27A associates with MPR trafficking in-
termediates forming at the TGN and early endosomes. For this 
purpose, we transiently expressed mCherry-OCRL1 or IPIP27A in 
COS-7 cells stably expressing low levels of GFP-CIMPR and per-
formed spinning-disk confocal time-lapse microscopy. There was 
extensive colocalization of GFP-CIMPR with mCherry-OCRL1 in 
both the perinuclear TGN and more peripheral endosomes (Figure 
3A and Supplemental Figure S3). Rapid time-lapse imaging under 
these conditions indicates the presence of OCRL1 in CIMPR-con-
taining structures, most likely corresponding to trafficking interme-
diates, budding from larger TGN and endosomal compartments 
(Figure 3A and Supplemental Videos S1 and S2). The budding 
structures sometimes appeared as short tubules or were more ve-
sicular in nature, and after detachment they moved away from the 
donor compartment. Time-lapse imaging revealed that mCherry-
IPIP27A was also present on CIMPR- and OCRL1-positive carriers 
(Figure 3B and Supplemental Video S3).
We next analyzed whether OCRL1 is present on other carriers 
that bud from early endosomes. Covisualization of mCherry-
OCRL1 with GFP-transferrin receptor (TfR), which is packaged into 
carriers destined for the plasma membrane or recycling endo-
somes (Maxfield and McGraw, 2004), revealed that TfR-containing 
tubular carriers are devoid of OCRL1 (Supplemental Figure S4A). 
We also analyzed Wls, which is trafficked in a retromer- and sort-
ing nexin 3–dependent manner from endosomes to the TGN 
(Harterink et al., 2011). OCRL1 was also absent from Wls contain-
ing tubular carriers emerging from endosomes (Supplemental 
Figure S4B).
Previous studies showed that the retromer-associated BAR do-
main protein SNX1 functions in endosome-to-TGN trafficking of 
CIMPR, where it contributes to the biogenesis of trafficking interme-
diates (Arighi et al., 2004; Carlton et al., 2004; Seaman, 2004). To 
determine whether the endosome-derived OCRL1-positive carriers 
also contain SNX1 or represent a distinct type of carrier, we covisual-
ized GFP-tagged SNX1 and mCherry-OCRL1 by time-lapse micros-
copy. As expected from previous work (Carlton et al., 2004), GFP-
SNX1 was present on tubular carriers emanating from endosomes 
(Figure 3C and Supplemental Videos S4 and S5). Although OCRL1 
was present on the same parental endosomes as SNX1, it was ab-
sent from the SNX1 carriers (Figure 3C and Supplemental Videos S4 
and S5). These results indicate that the OCRL1- and IPIP27A-con-
taining CIMPR carriers are distinct from those that contain SNX1 and 
vice versa.
with the indicated GST-tagged proteins as bait were incubated with HeLa cell extract, and bound OCRL1 and pacsin 2 
were detected by Western blotting. (C) Extracts of HeLa cells expressing the indicated tagged proteins were incubated 
with beads containing GST-tagged bait proteins and binding assessed by Western blotting with anti-GFP or anti-HA 
antibodies. (D) GST-tagged bait proteins were incubated with extracts from HeLa cells expressing GFP-tagged wild-type 
(WT) IPIP27A or the indicated point mutants (203PPPPPP208>AAAAAA, designated as P6>A6, 203PPP205>PAA, 
209RR210>AA, all in the 203PPPxPPRR210 motif; and 215PHGP218>AHGA, outside the motif), and binding was 
assessed by Western blotting with anti-GFP antibodies. (E) HeLa cells coexpressing Myc-IPIP27A and either GFP or 
GFP-pacsin 2 were subjected to coimmunoprecipitation with anti-Myc antibodies and analysis by Western blotting with 
anti-Myc and anti-GFP antibodies. (F) Beads containing GST-IPIP27A C-terminal fragment were incubated in the absence 
or presence of S-tagged OCRL1 with increasing concentrations of MBP or MBP-pacsin 2 SH3 domain as indicated and 
binding analyzed by Coomassie blue staining.
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acts in a dominant-negative manner to per-
turb endocytic traffic (Hyvola et al., 2006; 
Hou et al., 2011). Strikingly, the coexpres-
sion of GFP-OCRL1∆PIP2 together with 
IPIP27A resulted in elongated tubules ema-
nating from the perinuclear region and pe-
ripheral endosomal compartments that con-
tained both proteins (Figure 5A). GFP-CIMPR 
was present in the tubules, mainly in dis-
crete foci found along the tubule length 
(Figure 5B). The tubules were not observed 
when wild-type OCRL1 was coexpressed 
with IPIP27A, when OCRL1∆PIP2 was ex-
pressed in the absence of IPIP27A, or in the 
presence of IPIP27B, which cannot bind 
pacsin 2 (Figure 5A). These observations 
suggest that OCRL1∆PIP2 must engage 
with IPIP27A, and in turn pacsin 2, to cause 
membrane tubulation. This was confirmed 
by expressing mutant IPIP27A, unable to 
bind OCRL1 (F224A) or pacsin 2 (RRAA), 
both of which failed to support OCRL1∆PIP2-
dependent membrane tubulation (Figure 
5D). Taken together, these results support a 
functional role for the pacsin 2-IPIP27A-
OCRL1 complex in regulating TGN and en-
dosomal membrane dynamics.
CIMPR tubulation depends on both 
F-actin and microtubules
Previous studies indicated a role for OCRL1 
in regulating actin dynamics at various cel-
lular locations, where its ability to dephos-
phorylate PtdIns(4,5)P2 promotes localized 
actin turnover (Suchy and Nussbaum, 2002; 
Dambournet et al., 2011; Bohdanowicz 
et al., 2012; Kuhbacher et al., 2012; Marion 
et al., 2012; van Rahden et al., 2012; 
Nandez et al., 2014). Given that actin plays 
an important role in carrier biogenesis at 
the TGN and endosomes (Anitei and Ho-
flack, 2011), and the fact that pacsin 2 is 
intimately associated with the actin cyto-
skeleton (Kessels and Qualmann, 2004; 
Kostan et al., 2014; Quan and Robinson, 
2014), we reasoned that OCRL1, through 
binding via IPIP27A to pacsin 2, may func-
tion to locally regulate actin turnover during 
carrier morphogenesis and/or promote re-
moval of actin after carrier scission. In sup-
port of this hypothesis, we observed exces-
sive accumulation of actin in the perinuclear 
region and on endosomes upon IPIP27A 
depletion (Figure 6A). This is similar to what 
was previously reported for OCRL1 defi-
ciency (Vicinanza et al., 2011). Next we in-
vestigated whether the formation of aber-
rant CIMPR carriers in IPIP27A-depleted 
cells was dependent upon actin. To probe 
actin involvement, we treated cells with the 
actin polymerization inhibitor latrunculin A 
and monitored CIMPR dynamics. In control 
FIGURE 2: Pacsin 2 localization to endosomes and the Golgi apparatus. (A) COS-7 cells 
transiently transfected with GFP-pacsin 2, mCherry-OCRL1, and myc-IPIP27A were fixed, 
immunolabeled with antibodies raised against the myc epitope, golgin97, EEA1, or TfR (blue), as 
indicated, and examined by immunofluorescence microscopy. (B) COS-7 cells transiently 
transfected with GFP-OCRL1 were fixed, immunolabeled with antibodies raised against EEA1 
(red) and pacsin 2 (blue) as indicated, and examined by immunofluorescence microscopy. 
Arrowheads indicate colocalization on endosomes, and the arrow denotes colocalization on the 
TGN. (C) COS-7 cells transiently transfected with GFP-pacsin 2 D40K and mCh-OCRL1 with or 
without coexpression of the indicated myc-tagged IPIP27A construct were examined by 
fluorescence microscopy. Scale bars, 10 μm.
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involvement, we depleted the actin nucleation–promoting factors 
(NPFs) neural Wiskott–Aldrich syndrome protein (N-WASP) and the 
WASH complex. N-WASP functions in carrier biogenesis at the 
TGN (Anitei and Hoflack, 2011) and has also been implicated in 
regulating an OCRL1-sensitive pool of endosomal actin (Vicinanza 
et al., 2011). Of interest, N-WASP binds to and is activated by 
cells, latrunculin A treatment reduced the formation of CIMPR tu-
bules (Figure 6B), in line with previous studies showing that actin is 
required for CIMPR carrier biogenesis (Waguri et al., 2003; Anitei 
et al., 2010). Strikingly, latrunculin A treatment abrogated forma-
tion of CIMPR tubules in IPIP27A-depleted cells, confirming that 
they are also actin dependent (Figure 6B). To further probe actin 
FIGURE 3: OCRL1 and IPIP27A are present on endosome- and TGN-derived trafficking intermediates. (A) COS-7 cells 
were transfected with GFP-CIMPR, mCh-OCRL1, and myc-IPIP27A and imaged live at 37°C 24 h posttransfection using 
spinning-disk confocal microscopy. (i, ii) Two different cells indicating budding from an endosome (i) or from the TGN (ii). 
(B) COS-7 cells were cotransfected with GFP-OCRL1-WT and mApple-IPIP27A and imaged 24 h posttransfection at 
37°C using spinning-disk confocal microscopy. (C) COS-7 cells were cotransfected with GFP-SNX1, mCh-OCRL1, and 
myc-IPIP27A and imaged 24 h posttransfection at 37°C using spinning-disk confocal microscopy. For each experiment, 
budding events are shown, with the time elapsed in seconds. In all cases, the pink arrowheads indicate the parent 
structure, the blue arrowheads show where the carrier is emerging, and the orange arrowheads indicate when the 
carrier has detached from the parent structure. Scale bars, 10 μm.
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FIGURE 4: Effects of IPIP27A and pacsin depletion upon CIMPR dynamics. (A) HeLaM cells stably expressing GFP-
CIMPR were subjected to RNAi as indicated and Western blotting performed 72 h posttransfection with the indicated 
antibodies. (B–E) HeLaM cells stably expressing GFP-CIMPR were subjected to RNAi as indicated and imaged 72 h 
posttransfection at 37°C using spinning-disk confocal microscopy. Insets in B show magnifications of the boxed regions. 
(C) The length of GFP-CIMPR tubules from 16 control (luciferase) or IPIP27A-depleted cells from three independent 
experiments was measured, and the average tubule length in each cell was calculated. The overall mean tubule length 
for each condition is also indicated, with the SD shown by the error bars. Means of control and IPIP27A-depleted cells 
were compared using an unpaired t test using Welch’s correction; ***p < 0.001. (D) The mean number of GFP-CIMPR 
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OCRL1 (D422A) failed to rescue tubulation, indicating the impor-
tance of 5-phosphatase activity for OCRL1 function in CIMPR carrier 
biogenesis. Moreover, mutant OCRL1 deficient in binding to the 
F&H motif of IPIP27 (W739A; Pirruccello et al., 2011) was also un-
able to rescue tubulation, further indicating the importance of the 
OCRL1-IPIP27A interaction in regulating CIMPR dynamics.
OCRL1 5-phosphatase activity is curvature sensitive and 
stimulated by tripartite complex formation with IPIP27A 
and pacsin 2
The IPIP27A-mediated linking of OCRL1 to pacsin 2 would be pre-
dicted to enrich OCRL1 in domains of high membrane curvature 
such as those found at the neck of budding vesicles or tubules. 
Hence formation of the tripartite OCRL1/IPIP27A/pacsin 2 complex 
may represent a mechanism for enriching OCRL1 5-phosphatase ac-
tivity to trafficking intermediates at a late stage in their biogenesis. 
Previous work showed that the activity of another 5-phosphatase, 
synaptojanin, is sensitive to membrane curvature (Chang-Ileto et al., 
2011). We therefore examined whether the same was true for 
OCRL1. For this purpose, we incubated recombinant OCRL1 with 
liposomes of different curvature. As shown in Figure 8A, OCRL1 
5-phosphatase activity is higher toward PtdIns(4,5)P2 in high-curva-
ture liposomes (30 nm) than in those with lower curvature (200 nm). 
The degree of stimulation is comparable to that seen with synapto-
janin (Chang-Ileto et al., 2011). Next we assessed whether binding of 
IPIP27A in the absence or presence of pacsin 2 would affect OCRL1 
5-phosphatase activity (performed using 200-nm liposomes). 
IPIP27A alone resulted in a small (25–50%) but consistently observed 
reduction in OCRL1 5-phosphatase activity (Figure 8B). However, 
when the reaction was supplemented with pacsin 2, allowing tripar-
tite complex formation, there was a dramatic stimulation of OCRL1 
5-phosphatase activity (sevenfold increase, achieved at a 1:1 M ratio 
of IPIP27A to pacsin 2; Figure 8B). The interactions between OCRL1, 
IPIP27A, and pacsin 2 are required for stimulation. Mutant versions 
of IPIP27A deficient in binding to OCRL1 (F224A) or pacsin 2 
(RR>AA) or a pacsin 2 mutant deficient in IPIP27A binding (P428L) 
failed to stimulate activity (Figure 8C). Note also the loss of inhibition 
of OCRL1 activity with the F224A mutant of IPIP27A, confirming that 
the interaction between OCRL1 and IPIP27A is required for this in-
hibitory effect (Figure 8C). In contrast, abrogation of the IPIP27A–
pacsin interaction does not affect the IPIP27A-mediated inhibition of 
OCRL1 activity (Figure 8C).
PtdIns(4,5)P2 (Miki et al., 1996) and can bind directly to pacsin 2 
(Kessels and Qualmann, 2004). The WASH complex is a major regu-
lator of endosomal actin assembly and is important for several recy-
cling pathways (Derivery et al., 2009; Gomez and Billadeau, 2009; 
Duleh and Welch, 2010). Of interest, depletion of either N-WASP or 
WASH strongly impaired the formation of CIMPR tubules seen 
upon IPIP27A depletion (Figure 6C).
Previous work showed that CIMPR carrier biogenesis depends 
on microtubules in addition to actin (Waguri et al., 2003). We there-
fore investigated whether the aberrant CIMPR tubules seen in 
IPIP27A-depleted cells required intact microtubules. The tubules 
aligned with microtubules (Figure 6D), and microtubule depolymer-
ization induced by the drug nocodazole led to a complete abroga-
tion of membrane tubulation (Figure 6E). Taken together, our results 
indicate that both F-actin and microtubules are required for the gen-
eration of tubular TGN and endosome-derived CIMPR carriers in 
IPIP27A-depleted cells.
OCRL1 5-phosphatase activity regulates CIMPR carrier 
biogenesis
To investigate the requirement for OCRL1 in CIMPR carrier biogen-
esis, we stably expressed GFP-CIMPR at low levels in control and 
OCRL1-deficient Lowe syndrome fibroblasts (Figure 7A). In control 
cells, GFP-CIMPR was localized to the perinuclear TGN and more 
peripheral endosomes, as expected (Figure 7B). Time-lapse imag-
ing revealed formation of vesicular and short tubular CIMPR carriers 
at both compartments (Figure 7B). In Lowe syndrome fibroblasts, 
the steady-state distribution of GFP-CIMPR was similar to that in 
control cells (Figure 7B). However, time-lapse analysis revealed that 
CIMPR was more tubular in the Lowe syndrome cells, corresponding 
to aberrant formation of trafficking intermediates at the TGN and 
endosomes (Figure 7B). The phenotype was less dramatic than that 
seen upon IPIP27A depletion, possibly due to redundancy of OCRL1 
with the related phosphatase INPP5B, which also binds to IPIP27A 
(Swan et al., 2010; Noakes et al., 2011). Quantitation revealed that 
the number of tubules was significantly increased in the Lowe syn-
drome cells, although tubule length was unaltered (Figure 7, C and 
D). To determine whether the 5-phosphatase activity of OCRL1 is 
important for CIMPR carrier formation, we performed rescue experi-
ments. Expression of low levels of wild-type OCRL1 rescued the tu-
bulation phenotype, restoring the number of tubules to control lev-
els (Figure 7, E and F). In contrast, expression of catalytically inactive 
tubules per cell for each condition is indicated, with the SD of the samples shown by error bars. Means of control vs. 
IPIP27A-depleted cells were compared using a Mann–Whitney test; ***p < 0.001. (E) Time series of the indicated 
RNAi-treated cells, showing examples of carrier formation. The pink arrowheads indicate the parent structure, with the 
blue arrowheads highlighting an emerging carrier or tubule. The orange arrowheads indicate detachment of carriers in 
control-depleted cells. Times are indicated in seconds. (F–H) Cells were treated with luciferase (control), IPIP27A, or 
pacsin 2 siRNA independently or with IPIP27A and pacsin 2 siRNA used together (Double) and imaged 72 h 
posttransfection at 37°C using spinning-disk confocal microscopy. Insets indicate the zoomed areas. (G) The lengths of 
GFP-CIMPR tubules in the depleted cells (10–13 cells/condition from two independent experiments) were measured, 
and the average tubule length per cell is plotted on the graph as individual data points. The error bars indicate the SD. 
Medians were compared using a Kruskal–Wallis test, and adjusted p values calculated using Dunn’s multiple comparison 
test are shown; *p < 0.05, **p < 0.01, ***p < 0.001. (H) The average number of GFP-CIMPR tubules per cell for each 
condition. Error bars show the SD. Means were compared using one-way ANOVA, and adjusted p values were 
calculated using a Dunnett multiple comparison test; ***p < 0.001. (I–K) Cells were treated with the indicated siRNA and 
imaged 72 h posttransfection at 37°C using spinning-disk confocal microscopy. Insets indicate the zoomed areas. (J) The 
lengths of GFP-CIMPR tubules in the depleted cells (21 cells/condition from three independent experiments) were 
measured, and the average tubule length per cell is plotted on the graph as individual data points. The error bars 
indicate the SD. (K) Average number of GFP-CIMPR tubules per cell for each condition. Error bars show the SD. Means 
were compared using one-way ANOVA, and adjusted p values were calculated using a Dunnett multiple comparison 
test; **p < 0.01, ***p < 0.001. Scale bars, 10 μm.
98 | P. G. Billcliff, C. J. Noakes, Z. B. Mehta, et al. Molecular Biology of the Cell
with 30-nm liposomes (Figure 8E). Pacsin 2 can therefore pro-
mote OCRL1 activity by generating curvature or promoting as-
sociation with preexisting high-curvature membranes, both of 
which depend on the F-BAR domain. We also tested whether 
SNX9, a BAR domain protein that can bind directly to OCRL1 
(Nandez et al., 2014), would affect 5-phosphatase activity. 
As shown in Figure 8F, OCRL1 5-phosphatase activity was 
To better understand the mechanism of OCRL1 regulation, we 
repeated the experiments with a pacsin 2 mutant deficient in 
generating membrane curvature (K147E/K148E/K150E; Rao 
et al., 2010). As shown in Figure 8D, this mutant failed to stimu-
late OCRL1 5-phosphatase activity, confirming the importance of 
membrane curvature for OCRL1 activation. Of interest, stimula-
tion of OCRL1 activity with wild-type pacsin 2 was also observed 
FIGURE 5: Overexpression of OCRL1∆PIP2 in the presence of IPIP27A causes membrane tubulation. (A) HeLaM cells 
coexpressing GFP-OCRL1∆PIP2 (green) and Myc-IPIP27A were labeled with anti-Myc antibody (red) and imaged by 
fluorescence microscopy. Arrowheads indicate tubules present in the periphery and perinuclear regions of the cell. 
Asterisks indicate cells with low (*), medium (**) and high (***) GFP-OCRL1∆PIP2 expression. (B) HeLaM cells stably 
expressing GFP-CIMPR (green) were transfected with mApple-OCRL1∆PIP2 (red) and untagged IPIP27 and imaged at 
37°C using spinning-disk confocal microscopy at 24 h posttransfection. (C) HeLaM cells were transfected with GFP-
OCRL1∆PIP2 alone or with GFP-OCRL1∆PIP2 and either pcIPIP27A or Myc-IPIP27B. The cells were imaged as in B. 
(D) HeLaM cells were cotransfected with GFP-OCRL1∆PIP2 (green) and Myc-tagged IPIP27A wild type (WT), the F224A 
OCRL1-binding mutant, or the RR > AA pacsin 2 binding mutant and fixed 24 h posttransfection. Cells were labeled 
with anti-Myc antibodies (red) and analyzed by fluorescence microscopy. The number and lengths of tubules in 
14–16 cells/transfection in three independent experiments were counted. The top graph shows the average number 
of tubules per cell; error bars indicate SDs. Means were compared using one-way ANOVA, and adjusted p values 
calculated using Dunnett’s multiple comparison test are shown; *p = 0.244, **p = 0.0001. For the bottom graph, the 
lengths of tubules in 14–16 cells/transfection (two independent experiments) were measured and an average tubule 
length for each cell calculated and plotted. The means are indicated with error bars showing the SD. Means were 
compared using one-way ANOVA with Dunnett’s multiple comparison test; ***p < 0.001.
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OCRL1 5-phosphatase activity promotes dissolution 
of pacsin 2 tubules
Pacsin 2 binds to acidic lipids, including phosphatidic acid, and 
phosphoinositides such as PtdIns(4,5P)2 (Quan and Robinson, 2014). 
unaffected by SNX9. Taken together, these results indicate that 
IPIP27A-mediated linking of OCRL1 to the F-BAR protein pacsin 
2 stimulates its 5-phosphatase activity in a membrane curvature–
dependent manner.
FIGURE 6: CIMPR tubules induced by IPIP27A depletion require the actin cytoskeleton and microtubules. (A) HeLa cells 
treated with control (luciferase) or IPIP27A siRNA were fixed and labeled for actin using Alexa 488–phalloidin (green), 
together with an antibody raised against EEA1 (red). (B) HeLaM cells stably expressing GFP-CIMPR were treated with 
the indicated siRNA, then, at 72 h posttransfection, incubated in the absence or presence of 0.2 μM latrunculin A for 1 h 
at 37°C, and then imaged using spinning-disk confocal microscopy. Insets indicate the zoomed areas. The length of 
tubules from 21 cells from three independent experiments was measured for each treatment, and the average tubule 
length in each cell was calculated. (C) HeLaM cells stably expressing GFP-CIMPR were treated with the indicated siRNA, 
and imaged 72 h posttransfection at 37°C using spinning-disk confocal microscopy. Insets indicate the zoomed areas. 
The length of GFP-CIMPR tubules from 21 cells from three independent experiments was measured for each treatment, 
and the average tubule length in each cell was calculated. (D) HeLaM cells stably expressing GFP-CIMPR were treated 
with the indicated siRNA and, 72 h later, fixed and immunolabeled with an antibody raised against α-tubulin. (E) HeLaM 
cells stably expressing GFP-CIMPR were treated with the indicated siRNA, then, 72 h posttransfection, incubated in the 
absence or presence of 10 μM nocodazole for 2 h at 37°C, and then imaged using spinning-disk confocal microscopy. 
Insets indicate the zoomed areas. The length of tubules from 21 cells from three independent experiments was 
measured for each treatment, and the average tubule length in each cell was calculated. For all data, medians were 
compared using a Kruskal–Wallis test, and adjusted p values calculated using Dunn’s multiple comparison test are 
shown; ***p < 0.001. Scale bars, 10 μm.
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Pacsin 2 tubules were still prevalent when the 5-phosphatase do-
main of OCRL1 domain, fused to the FK506-binding protein 
(FKBP), was coexpressed in the absence of rapamycin (Figure 8, G 
and H). However, on addition of rapamycin to stimulate pacsin 
2-OCRL1 heterodimerization, tubulation was completely abol-
ished (Figure 8, G and H). This effect depended on the 5-phospha-
tase activity of OCRL1, because catalytically inactive OCRL1 had 
no effect on pacsin 2–induced tubulation, even though it was effi-
ciently recruited to the tubules (Figure 8, G and H). These results 
This raised the possibility that OCRL1-mediated PtdIns(4,5P)2 hydro-
lysis could influence the membrane binding or tubulation properties 
of pacsin 2. To test this hypothesis, we took advantage of a rapamy-
cin-based heterodimerization assay to inducibly recruit the OCRL1 
catalytic domain to ectopically generated pacsin 2 tubules. As 
shown previously (Rao et al., 2010; Shimada et al., 2010), overex-
pression of the pacsin 2 F-BAR domain, in this case fused to GFP and 
the rapamycin-binding domain of mTOR (FRB), induced extensive 
membrane tubulation when expressed in cells (Figure 8, G and H). 
FIGURE 7:  CIMPR dynamics in Lowe syndrome patient fibroblasts. Dermal fibroblasts derived from either one of two 
Lowe syndrome patients (Patient A, Patient B) or from a control patient were lentivirally transduced with GFP-CIMPR. 
(A) Western blot of cell lysates from GFP-CIMPR–expressing control or patient fibroblasts, using antibodies raised 
against the indicated antigens. (B–D) GFP-CIMPR–expressing control or patient fibroblasts were imaged at 37°C using 
spinning-disk confocal microscopy. Insets indicate the zoomed areas, with arrows denoting tubules. Scale bar, 10 μm. 
(C) Number of tubules from 21 control or patient cells from three independent experiments was measured, and the 
mean tubule number was calculated, with the SD shown by the error bars. Medians were compared using a Kruskal–
Wallis test, and adjusted p values calculated using Dunn’s multiple comparison test are shown; ***p < 0.001. 
(D) Average tubule length in each cell was also calculated, with the SD shown by the error bars. (E, F) Lowe syndrome 
patient cells stably expressing GFP-CIMPR were lentivirally transduced with mApple OCRL1 WT, D422A, or W739A and 
imaged at 37°C using spinning-disk confocal microscopy. (E) Number of tubules from 21 control or patient cells from 
three independent experiments was measured, and the mean tubule number was calculated, with the SD shown by the 
error bars. Means were compared using one-way ANOVA, and adjusted p values calculated using Dunnett’s multiple 
comparison test are shown; ***p < 0.001. (F) Average tubule length in each cell was also calculated, with the SD shown 
by the error bars.
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1999). OCRL1 and IPIP27A therefore appear to function in biogen-
esis of both anterograde and retrograde CIMPR trafficking interme-
diates at the TGN and early endosome, respectively.
Pacsin 2 preferentially binds to high-curvature membranes, such 
as those found at the neck of budding vesicles (Qualmann et al., 
2011). Indeed, pacsin 2 associates with clathrin-coated buds at the 
plasma membrane only at a very late stage, immediately before 
scission, coinciding with the formation of a high-curvature vesicle 
neck (Qualmann et al., 2011; Taylor et al., 2011). Hence IPIP27A-
mediated engagement of pacsin 2 would be expected to recruit 
OCRL1 to newly forming trafficking intermediates at a late stage, 
immediately preceding or coinciding with scission. It is known that 
Rab GTPases are required for targeting OCRL1 to the membrane 
(Hyvola et al., 2006; Hou et al., 2011). We therefore envisage a 
model in which OCRL1 is first recruited to the membrane by Rab 
GTPases, and, once bound to the membrane, engages, via IPIP27A, 
with pacsin 2 in regions of high membrane curvature corresponding 
to the neck of late-stage budding intermediates. Before pacsin 2 
binding, OCRL1 activity is attenuated by IPIP27A. Once OCRL1 as-
sociates with pacsin 2, catalytic activity is stimulated, ensuring that 
the timing of enzymatic activation and hydrolysis of PtdIns(4,5)P2 
coincides with scission or release of the newly formed trafficking in-
termediate. Perturbation of this mechanism would be expected to 
lead to a membrane scission defect, which is in accordance with the 
aberrant CIMPR tubulation we see upon loss of OCRL1 or IPIP27A. 
An analogous mechanism has been proposed for the activation of 
synaptojanin on endophilin-generated trafficking intermediates at 
the plasma membrane (Chang-Ileto et al., 2011).
Our results indicate that OCRL1-mediated PtdIns(4,5)P2 hydroly-
sis is important for CIMPR carrier biogenesis at the TGN and endo-
somes. This could reflect a direct physiological role for PtdIns(4,5)P2 
in carrier formation at these locations, where it may recruit and/or 
activate components of the trafficking machinery. PtdIns(4,5)P2 has 
been detected at the TGN and endosomes (Watt et al., 2002; Shi 
et al., 2012), and the actin machinery, which is often regulated by 
PtdIns(4,5)P2, is known to promote carrier biogenesis at both com-
partments (Anitei and Hoflack, 2011). Moreover, PtdIns4P 5-kinases 
have been localized to the Golgi and endosomes, indicating that 
PtdIns(4,5)P2 synthesis can occur at these compartments (Godi 
et al., 1999; Sun et al., 2013). Of interest, N-WASP, which promotes 
clathrin and AP1 carrier biogenesis at the TGN (Anitei et al., 2010), 
is activated by binding to PtdIns(4,5)P2 and pacsin 2, which itself is a 
PtdIns(4,5)P2-binding protein (Miki et al., 1996; Kessels and Qual-
mann, 2004). Hence OCRL1 may remove PtdIns(4,5)P2 and in turn 
promote disassembly of actin and actin-associated machinery dur-
ing late stages of carrier formation at the TGN and endosomes. In-
deed, depletion of IPIP27A leads to ectopic actin accumulation at 
these compartments, and the aberrant carriers generated in 
IPIP27A-depleted cells are actin dependent. Another possibility is 
that OCRL1 functions to remove ectopic PtdIns(4,5)P2 from TGN 
and endosome carriers. PtdIns(4,5)P2 plays a key role in recruiting 
adaptors and accessory factors to clathrin-coated pits at the plasma 
membrane (McMahon and Boucrot, 2011). OCRL1 may contribute 
to fidelity of carrier formation at the TGN and endosomes by pre-
venting inappropriate recruitment of plasma membrane adaptors, 
many of which have a high propensity to bind to clathrin, at these 
locations. PtdIns(4,5)P2 hydrolysis by OCRL1 could therefore be 
viewed as a proofreading step to ensure correct adaptor 
incorporation into clathrin buds at the TGN and endosomes. In line 
with this possibility, ectopic endosomal accumulation of PtdIns(4,5)
P2 and its effectors has been reported in OCRL1-deficient cells (Ben 
El Kadhi et al., 2011; Vicinanza et al., 2011). Of interest, the product 
indicate that OCRL1-catalyzed PtdIns(4,5P)2 hydrolysis has the 
ability to destabilize membrane association of pacsin 2 and/or pro-
mote scission of pacsin 2 membrane tubules in vivo.
Depletion of pacsin 2 impairs CIMPR recycling
Loss of either OCRL1 or IPIP27A impairs MPR trafficking at the TGN/
endosome interface (Cui et al., 2010; Noakes et al., 2011; Vicinanza 
et al., 2011; van Rahden et al., 2012). Our results suggest that 
OCRL1 and IPIP27A act together with pacsin 2 in generating CIMPR-
containing trafficking intermediates. We therefore predict that pac-
sin 2 is required for CIMPR trafficking at the TGN/endosome inter-
face. To functionally test this possibility, we depleted pacsin 2 by 
RNA interference and analyzed CIMPR trafficking using a well-char-
acterized chimeric CD8-CIMPR reporter (Seaman, 2004). This re-
porter offers a convenient way to assess directly endosome-to- TGN 
delivery of the CIMPR. As shown in Figure 9, A–C, depletion of pac-
sin 2 inhibited trafficking of CD8-CIMPR from endosomes to the 
TGN. The extent of trafficking inhibition was comparable to that 
seen upon IPIP27A depletion (Figure 9, A–C). This result indicates a 
role for pacsin 2 in recycling of CIMPR from endosomes to TGN, 
which is also affected by loss of OCRL1 or IPIP27A (Noakes et al., 
2011; Vicinanza et al., 2011; van Rahden et al., 2012).
DISCUSSION
Previous studies revealed CIMPR trafficking defects upon loss of 
OCRL1 (Choudhury et al., 2005; Cui et al., 2010; Vicinanza et al., 
2011; van Rahden et al., 2012). However, it has been unclear 
whether these defects reflect a global perturbation of organelle ho-
meostasis, arising from altered phosphoinositide levels, or indicate 
a more direct role for OCRL1 in the trafficking process (Pirruccello 
and De Camilli, 2012). Our findings support the latter hypothesis. 
IPIP27A links OCRL1 directly to a component of the trafficking ma-
chinery, pacsin 2, and we observe OCRL1 in newly formed traffick-
ing intermediates exiting from both TGN and early endosomal com-
partments. The OCRL1- and IPIP27A-positive CIMPR trafficking 
intermediates are distinct from those containing SNX1 and lack the 
endocytic recycling cargoes transferrin receptor and Wls. The close 
association of OCRL1 with CIMPR trafficking machinery that we 
observe is in good agreement with a report showing that CIMPR 
and the AP1-associated clathrin adaptor epsinR are major constitu-
ents of OCRL1 complexes isolated from cells (Nandez et al., 2014). 
Moreover, proteomic fractionation profiling indicates that CIMPR is 
the most highly correlated protein with IPIP27A, strongly supporting 
the view that IPIP27A is associated with CIMPR trafficking intermedi-
ates (Borner et al., 2014). Based on this method, IPIP27A also cor-
relates well with Vti1B, which binds epsinR, as well as pacsin 2, and 
OCRL1 is highly correlated with AP1 and epsinR, consistent with the 
biochemistry of OCRL1 complexes (Borner et al., 2014; Nandez 
et al., 2014).
Although previous studies focused mainly on the role of OCRL1 
and IPIP27A in retrograde endosome-to-TGN traffic (Choudhury 
et al., 2005; Noakes et al., 2011; Vicinanza et al., 2011; van Rahden 
et al., 2012), our results support a role for OCRL1 and IPIP27A also 
in anterograde TGN-to-endosome traffic. This is consistent with the 
presence of OCRL1 in clathrin-coated buds at the TGN (Choudhury 
et al., 2005) and the high degree of correlation between IPIP27A 
and lysosomal hydrolases, which are trafficked in the anterograde 
TGN-to- endosome direction, seen in proteomic fractionation profil-
ing (Borner et al., 2014). The close association of OCRL1 with CIMPR 
and lysosomal hydrolase trafficking also helps explain why Lowe 
syndrome patients have elevated hydrolases in their plasma, which 
is indicative of missorting at the TGN (Ungewickell and Majerus, 
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FIGURE 8: OCRL1 5-phosphatase activity is stimulated by tripartite complex formation with IPIP27A and pacsin 2 and 
by itself promotes dissolution of pacsin 2 tubules. (A–E) OCRL1 5-phosphatase activity was measured using a malachite 
green assay, as described in Materials and Methods, in the presence or absence of the indicated lipid vesicles and 
proteins. (A) His/S-tagged OCRL1 (30 nM) was incubated with 100 μM of PtdIns(4,5)P2 -containing liposomes of the 
indicated sizes. (B) His/S-OCRL1 (30 nM) was incubated with 100 μM PtdIns(4,5)P2–containing, 200-nm-diameter 
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liposomes in the presence or absence of various concentrations of GST-IPIP27A C-terminal fragment (192–249) and 
GST-pacsin 2, as indicated. (C) His/S-OCRL1 (30 nM) was incubated with 100 μM PtdIns(4,5)P2–containing, 200-nm-
diameter liposomes in the presence or absence of WT or mutant forms of GST-IPIP27A C-terminal fragment (180 nM) or 
GST-pacsin 2 (36 nM), as indicated. (D) His/S-OCRL1 (30 nM) was incubated with 100 μM PtdIns(4,5)P2–containing, 
200-nm-diameter liposomes in the presence or absence of WT IPIP27A C-terminal fragment (180 nM) and either 36 nM 
WT or the indicated concentrations of a GST-pacsin 2 mutant deficient in membrane tubulation activity, as indicated. 
(E) His/S-OCRL1 (30 nM) was incubated with 100 μM PtdIns(4,5)P2–containing, 200- or 30-nm-diameter liposomes as 
indicated in the presence or absence of WT IPIP27A C-terminal fragment (180 nM) and 36 nM GST-pacsin 2. The data 
set for each liposome size was normalized to 100%. (F) His/S-OCRL1 (30 nM) was incubated with 100 μM PtdIns(4,5)P2–
containing, 200-nm-diameter liposomes in the presence or absence of GST-IPIP27A WT C-terminal fragment (180 nM), 
WT GST-pacsin 2 (36 nM), or various concentrations of GST-SNX9, as indicated. For B–F, data are shown as a percentage 
of OCRL1 5-phosphatase activity when incubated alone. For A–E, means were compared using either Student’s t test 
(A) or one-way ANOVA (B–F), and adjusted p values calculated using Dunnett’s multiple comparison test are shown for 
the indicated pairwise comparisons; **p < 0.01, ***p < 0.001. The results are from three independent experiments, each 
repeated in triplicate. (G, H) COS-7 cells were transiently cotransfected with GFP-FRB-pacsin 2 F-BAR (green) and either 
the WT or D422A 5-phosphatase domain of OCRL1 fused to mRFP and FKBP (red), as indicated. Cells were then 
incubated in the presence or absence of 1 μM rapamycin for 1 h at 37°C and then fixed and examined by wide-field 
microscopy (G). Scale bar, 10 μm. (H) Percentage of cells containing pacsin 2-F-BAR tubules for the indicated conditions 
in four independent experiments was measured. The error bars show the SD. Means were compared using Student’s 
t test, and p-values are shown; ***p < 0.001.
FIGURE 9: Pacsin 2 depletion impairs CIMPR recycling. (A) HeLaM CD8-CIMPR cells treated with luciferase (control), 
IPIP27A, or pacsin 2 siRNA were incubated on ice with CD8 antibody and either fixed immediately (0 min) or warmed to 
37°C for 8 or 30 min before fixation and labeling with antibodies to EEA1 (blue) or golgin97 (red). CD8 was detected 
with appropriate secondary antibodies (green). Scale bar, 10 μm. (B, C) CD8-CIMPR recycling was quantified by 
determining the extent of colocalization between endocytosed CD8-CIMPR and golgin97 after incubation at 37°C for 
30 min relative to the total CD8-CIMPR fluorescence (B) or the percentage of cells with peripheral (endosomal) CD8 
staining at 30 min (C). Results are from two independent experiments (n = 25 and 100 cells for each knockdown in B and 
C, respectively) and are shown as mean + SD. Means were compared using one-way ANOVA, and adjusted p values 
were calculated using Dunnett’s multiple comparison test; ***p < 0.001, **p = 0.003, *p = 0.01.
0 
m
in
ut
es
Control RNAi IPIP27A RNAi PACSIN2 RNAi
8 
m
in
ut
es
Control RNAi
Golgin97 EEA1 MergeCD8-CIMPR
30
 m
in
ut
es
Control RNAi
IPIP27A RNAi
Pacsin 2 RNAi
Golgin97 EEA1 MergeCD8-CIMPR
A B
0
20
40
60
80
100
120
140
TG
N
 d
el
iv
er
y 
of
 C
D
8-
C
IM
PR
 
******
C
Control IPIP27A KD Pacsin 2 KD
0
20
40
60
80
*
**
%
 c
el
ls
 w
ith
 p
er
ip
he
ra
l M
P
R
Control IPIP27A KD Pacsin 2 KD
104 | P. G. Billcliff, C. J. Noakes, Z. B. Mehta, et al. Molecular Biology of the Cell
tional point mutants were generated by PCR using the QuikChange 
method (Stratagene, La Jolla, CA). Standard molecular biology 
methods were used to clone pacsin 2 (IMAGE clone 5173129) into 
pEGFP-C2 (BD BioSciences) or a modified pcDNA3.1(-) (Stratagene) 
containing an N-terminal mCherry tag, and point mutations were 
introduced as described to generate the P478L and D40K mutants 
for expression in mammalian cell lines. Tagged OCRL1 and IPIP27A 
were cloned into the XLG3 vector (kindly provided by Peter Cullen, 
University of Bristol, Bristol, United Kingdom) by standard molecular 
biology methods. Similarly, GFP-CIMPR (cDNA kindly provided by 
Matthew Seaman, University of Cambridge, Cambridge, United 
Kingdom) was also cloned into the XLG3 vector. For bacterial ex-
pression of recombinant pacsin 2 proteins for antibody production, 
a fragment encompassing amino acids 305–387 was cloned into 
pGex-4T-2. Similarly, for bacterial expression of recombinant GST-
tagged pacsin 2 and SNX9 used in lipid phosphatase assays, DNA 
encoding full-length protein was cloned into pGEX-4T-2. For the 
rapamycin-based heterodimerization assay, the F-BAR domain of 
pacsin 2 was inserted 3′ to GFP and the rapamycin-binding domain 
of mTOR (FRB) to generate GFP-FRB-pacsin 2 F-BAR. The 5-phos-
phatase domain of OCRL1 (amino acids 237–539) was inserted 3′ to 
monomeric red fluorescent protein (mRFP) and FKBP to generate 
mRFP-FKBP-OCRL1 5-PTase, with site-directed mutagenesis used 
to create a D422A mutant deficient in 5-phosphatase activity. All 
constructs were verified by sequencing using GATC Biotech 
(Konstanz, Germany). Primers were synthesized by MWG Biotech 
(Ebersburg, Germany), and sequences for all manipulations are 
available upon request. The GFP-TfR and GFP-Rab constructs were 
a kind gift from Philip Woodman (University of Manchester, Man-
chester, United Kingdom). The GFP-SNX1 construct was a kind gift 
of Peter Cullen (University of Bristol), and the GFP-Wls construct was 
a kind gift of Barth Grant (Rutgers University, New Brunswick, NJ).
Cell culture, transfection, and RNA interference
HeLa, HeLaM, and COS-7 cells were cultured at 37°C and 5% CO2 
in DMEM supplemented with 10% Hyclone fetal bovine serum 
(Thermo Scientific, Waltham, MA), 1% penicillin/streptomycin 
(100 U/ml), and 1 mM l-glutamine. Human dermal fibroblasts 
(ATCC) and Lowe syndrome patient fibroblasts (Baylor College of 
Medicine, Houston, TX) were grown in the same DMEM-based 
medium, with the addition of 1% nonessential amino acid solution 
(Sigma-Aldrich). HelaM cells stably expressing CD8-CIMPR or GFP-
CIMPR (kindly provided by Matthew Seaman, University of Cam-
bridge) were grown in the same medium supplemented with 0.5 
mg/ml G418. Immortalized human retinal pigment cells (hTERT 
RPE-1) were cultured in DMEM/F12 supplemented as described 
(minus G418) and with the addition of 10 μg/ml hygromycin B. Cells 
were cultured in antibiotic-free medium for all RNAi experiments. 
DNA transfections were performed with X-tremeGENE HP or 
FuGENE HD (Roche Diagnostics, Risch-Rotkrequz, Switzerland) 
according to the manufacturer’s instructions. A total of 1 μg DNA 
per 3.5-cm dish was used. Cells were assayed between 18 and 24 h 
after transfection. RNAi was performed using Interferin (Polyplus, 
Illkirch-Graffenstaden, France) and 20 nM siRNA. Cells were assayed 
72 h after transfection. For IPIP27A and pacsin 2 KD, the following 
oligos were used: IPIP27A (1, GUGCUGACCUAGUGGCGGA; 
4, GGUGACAGACUCAG CCCAA) and pacsin 2 (2, CCCUUAAUGU-
CCCGAGCAA; 4, CUGAGGUGGUUCCGAGCCA). Both oligos for 
each target displayed the same phenotype. WASH was depleted 
using the oligos 2, UGUCGGAUCUCUUCAACAA, and 3, GC-
CAAGAUUGAGAAGAUCA. N-WASP was depleted with a SMART-
pool consisting of four oligos. SNX1 was depleted using the oligo 
of OCRL1, PtdIns4P, binds to TGN and endosome-associated clath-
rin adaptors, including epsinR (Santiago-Tirado and Bretscher, 
2011). Hence, in addition to removing PtdIns(4,5)P2, OCRL1 may 
also act in a positive capacity to promote or stabilize membrane re-
cruitment of PtdIns4P-binding adaptors during clathrin vesicle for-
mation at the TGN and endosomes.
Although our results indicate a role for the OCRL1/IPIP27A/pac-
sin 2 complex at the TGN and endosomes, we believe the same 
complex is likely to function in clathrin vesicle biogenesis at the 
plasma membrane. OCRL1 and pacsin 2 are both present in late-
stage clathrin-coated pits (Erdmann et al., 2007; Taylor et al., 2011; 
Nandez et al., 2014), and proteomic analysis of clathrin-coated ves-
icle fractions showed that OCRL1 and IPIP27A are present in both 
plasma membrane– and TGN/endosome-derived vesicles (Hirst 
et al., 2012). Hence OCRL1 may be similarly regulated by IPIP27A 
and pacsin 2 during clathrin vesicle biogenesis at the plasma mem-
brane as it is on endomembranes. In contrast, interaction with 
SNX9, which does not affect OCRL1 catalytic activity, appears re-
stricted to the plasma membrane (Nandez et al., 2014). It is also 
worth noting that pacsin 2 functions in a number of other processes 
that require membrane remodeling and actin engagement, includ-
ing cytokinesis and caveolae formation (Hansen et al., 2011; Senju 
et al., 2011; Smith and Chircop, 2012; Takeda et al., 2013). It will be 
interesting to investigate whether OCRL1 participates in these pro-
cesses through binding via IPIP27A to pacsin 2. Furthermore, be-
cause IPIP27A also binds to the related 5-phosphatase INPP5B, it is 
possible that INPP5B could participate in additional pacsin 2–de-
pendent processes (Swan et al., 2010; Noakes et al., 2011). Further 
studies are required to examine these possibilities.
MATERIALS AND METHODS
Materials and antibodies
Reagents were obtained from Sigma-Aldrich (St. Louis, MO), Merck 
(Kenilworth, NJ), or Fisher Scientific (Hampton, NH) unless otherwise 
specified. The following antibodies were used: sheep anti-IPIP27A 
and B (Noakes et al., 2011); mouse anti–α-tubulin (Keith Gull, Univer-
sity of Oxford, Oxford, United Kingdom); mouse anti-CD8 (C7423; 
Sigma-Aldrich); goat anti-EEA1 (N19; Santa Cruz Biotechnology, Dal-
las, TX); mouse anti-EEA1 (610456; BD Biosciences, Franklin Lakes, 
NJ); sheep anti-GFP (Diao et al., 2003); sheep anti–glutathione S-
transferase (GST; Hyvola et al., 2006); rabbit anti-golgin97 (Nobuhiro 
Nakamura, Kyoto Sangyo University, Kyoto, Japan); rabbit anti-Myc 
(C3956; Sigma-Aldrich); mouse anti-SNX1 (611482; BD Biosciences); 
mouse anti-TfR (H68.4; Zymed, Waltham, MA); and sheep anti-
TGN46 (Vas Ponnambalam, University of Leeds, Leeds, United King-
dom). Sheep polyclonal anti–pacsin 2 antibodies were raised against 
human pacsin 2 by injecting an N-terminal GST-tagged pacsin 2 frag-
ment (amino acids 305–387, corresponding to the region of least 
similarity to pacsin 1 and 3) into sheep (conducted by the Scottish 
National Blood Transfusion Service, Edinburgh, United Kingdom). 
Anti–pacsin 2 antibodies were then purified on glutathione beads 
(GE Healthcare) using the same antigen. Alexa 594 and 647–conju-
gated phalloidin were bought from Molecular Probes. Alexa 488– 
and 594–conjugated and Cy3- and Cy5-conjugated secondary anti-
bodies were from Molecular Probes (Eugene, OR) and Jackson 
ImmunoLabs (West Grove, PA), respectively. Horseradish peroxidase–
conjugated secondary antibodies were from Santa Cruz Biotechnol-
ogy or Tago Immunochemicals (Limerick, PA).
Molecular biology
IPIP27A and OCRL1 (isoform a) constructs have been described pre-
viously (Choudhury et al., 2005; 2009; Noakes et al., 2011). Addi-
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60× objective, and images were taken using a MicroMax cooled, 
slow scan CCD camera (Roper Scientific, Trenton, NJ) controlled by 
Metavue software (MDS Analytical Technologies, Sunnyvale, CA). 
Images were processed using ImageJ (National Institutes of Health, 
Bethesda, MD) and Adobe Photoshop Creative Suite 5. Figures 
were assembled in Adobe Illustrator Creative Suite 5. For spinning-
disk confocal microscopy cells, were plated in 35-mm glass-bot-
tomed cell culture dishes (MatTek, Ashland, MA) and transfected as 
described. Cells were imaged using 100% laser power in CO2-inde-
pendent medium at 37°C using a Zeiss Axio-Observer Z1 spinning-
disk confocal microscope (63× oil objective) with a laser-based Defi-
nite Focus system. Movies were captured with a Photometrics 
Evolve electron-multiplying charge-coupled device camera, and 
SlideBook software (3i, Denver, CO) was used for image acquisition. 
Movies were recorded using a range of exposure times as indicated 
in the legends to the supplemental videos. Times were calculated 
using 1/acquisition frequency (hertz) to give the total exposure time 
per frame.
Immunoprecipitation
Cells were lysed on ice for 20 min in HMNT buffer (20 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid [HEPES], pH 7.4, 
5 mM MgCl2, 0.1 M NaCl2, 0.5% [wt/vol] Triton X-100, and Protease 
Inhibitor Cocktail III [Calbiochem, Kenilworth, NJ]) using 500 μl per 
10-cm dish. Lysates were clarified by centrifugation at full speed in a 
microfuge for 10 min at 4°C, followed by the addition of 2 μg of the 
appropriate primary antibody (per 300 μl of lysate) and incubation at 
4°C for 2 h. Immune complexes were collected on 10 μl of protein A 
or protein G–Sepharose (Invitrogen, Carlsbad, CA) for 1 h at 4°C 
and analyzed by SDS–PAGE and Western blotting.
Protein-binding experiments
GST-tagged bait protein (10–80 μg) coupled to 10 μl of glutathi-
one-Sepharose was incubated with 250 μl of HNMT cell lysate for 
2 h at 4°C. Competition binding with recombinant proteins was 
performed by coupling 1 μg of GST-IPIP27A C-terminal fragment 
(amino acids 192–249) to glutathione-Sepharose and incubation in 
100 μl of HNMT containing 100 μg/ml of BSA with 3 μg of histidine 
(His)/S-tagged OCRL1 and increasing molar ratios of MBP or MBP-
pacsin 2 SH3 domain (0.5–100 μg) for 2 h at 4°C. After washing in 
HNMT, bounds proteins were eluted in SDS sample buffer and 
analyzed by SDS–PAGE and Western blotting or Coomassie blue 
staining.
Lipid phosphatase assays
Lipids (1,2-dioleoyl-sn-glycero-3-phosphocholine [DOPC], 1,2-dio-
leoyl-sn-glycero-3-phospho-l-serine [DOPS], and natural PtdIns(4,5)
P2) were obtained from Avanti Polar Lipids (Alabaster, AL). All other 
chemicals were from Sigma-Aldrich and of the highest grade avail-
able. Lipid vesicles containing 60 mol% DOPC, 30 mol% DOPS, and 
10 mol% natural PtdIns(4,5)P2 were prepared by extrusion. The lipid 
mixture of DOPC, DOPS, and PtdIns(4,5)P2 was dissolved in chloro-
form/methanol (2:1). The lipid solution was dried by evaporation un-
der nitrogen gas. The dried lipid was then hydrated using 20 mM 
HEPES, pH 7.4, to a final lipid concentration of 1 mM for 1 h at room 
temperature. Once the lipids were fully hydrated, the lipid mixtures 
were extruded using polycarbonate membranes with pore sizes of 30 
and 200 nm, respectively. For the activity assay, His/S-OCRL1 (30 nM) 
was allowed to interact with the indicated proteins on ice for 20 min 
in 20 mM HEPES, pH 7.4, containing 100 mM NaCl, 4 mM MgCl2, 
and 0.5 mM dithiothreitol. The phosphatase activity was monitored 
as previously described (Mak et al., 2011). The phosphatase reaction 
AAGAACAAGACCAAGAGCCAC (Carlton et al., 2004). All oligos 
were obtained from Dharmacon (Lafayette, CO). Luciferase (GL2, 
CGUACGCGGAAUACUUCGATT; Eurogentec, Liege, Belgium) was 
used as a negative control.
Lentivirus production
HEK-293LTV cells (Cell Biolabs, San Diego, CA) were cultured to 
70–80% confluency in 10-cm dishes. We added 27 μl of branched 
polyethylenimine (PEI; 1 mg/ml) to 223 μl of serum-free DMEM 
and incubated at room temperature for 2 min. A 6-μg amount of 
XLG3 containing mApple-tagged OCRL1 or GFP-CIMPR was di-
luted with 4.5 μg of psPAX2 and 3 μg of pMD2.G lentiviral packag-
ing vectors (kindly provided by Martin Humphries, University of 
Manchester) in 250 μl of serum-free DMEM and then mixed with 
the PEI solution. The cell medium was replaced with 5 ml of pre-
warmed antibiotic-free medium, and after 20 min of incubation at 
room temperature, the transfection mixture was added to the 
cells. After 6–8 h of incubation at 37°C, the medium was replaced 
with 10 ml of prewarmed antibiotic-free medium and kept at 37°C 
overnight. The next day, 100 μl of sodium butyrate (1 M stock) was 
added to the cell medium. The cells were incubated for 8 h at 
37°C, and then the medium was replaced with antibiotic-free me-
dium. Medium containing virus was harvested at 72 h, clarified by 
centrifugation and filtration through a 0.45-μm filter, and stored at 
−80°C. To infect fibroblast cells, lentivirus solution was added to 
trypsinized cells at the time of plating (2 ml of virus per 35-cm 
culture dish). The cells were grown for 72 h, assessed for transduc-
tion by fluorescence microscopy, and passaged two or three times 
before use in experiments.
Generation of IPIP27A-knockout cells by clustered regularly 
interspaced short palindromic repeats
The guide sequence in the coding region of IPIP27A (GAAGCCTG 
CATTGTCCAC) was designed and cloned into the pD1301 vector 
by Horizon Discovery (Waterbeach, UK) and provided as a part 
of the Horizon clustered regularly interspaced short palindromic 
repeat reagents for the Knockout Generation Program. HeLaM 
cells were transfected with the pD1301 plasmid, and 24 h later, 
the cells were counted and diluted into one 15-cm dish at a den-
sity of 300 cells. The dish was grown for 10 d until visible colonies 
had formed. Individual colonies were trypsinized, reseeded onto 
96-well plate wells, and allowed to reach confluency. Fifteen 
clones were screened for IPIP27A knockout by Western blotting 
with an anti-IPIP27A antibody, and positive clones were retained 
and cultured.
CD8-CIMPR trafficking assay
CD8-CIMPR trafficking assays were performed according to Noakes 
et al. (2011).
Fluorescence microscopy
Cells were grown on coverslips and fixed in either ice-cold methanol 
for 4 min at −20°C (for staining with anti–α-tubulin) or in paraformal-
dehyde (PFA; 3% [wt/vol] in phosphate-buffered saline [PBS]) for 
20 min at room temperature and then washed three times in PBS. 
Cells fixed in PFA were permeabilized by incubation in 0.1% Triton 
X-100 in PBS for 4 min and then washed three times in PBS. Cover-
slips were incubated for 20 min at room temperature with primary 
antibodies and then fluorophore-conjugated secondary antibodies 
(diluted into PBS containing 0.5 mg/ml bovine serum albumin [BSA]) 
and 100 ng/ml Hoechst 33342 before mounting in Mowiol. Slides 
were viewed using an Olympus BX60 upright microscope using a 
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was started by addition of lipid vesicles. After incubation at 37°C 
for 20 min, the reaction was stopped by adding equal volumes of 
malachite green dye, and the resulting absorbance was read at 
625 nm.
Microscopy quantitation and statistical analysis
Quantitation of colocalization was performed using the Coloc2 
plug-in in ImageJ, with Pearson’s r from 64 cells determined. The 
CD8-CIMPR recycling experiments were quantified by scoring the 
phenotypes of 50–100 cells from two or three independent experi-
ments or by measuring the extent of colocalization between endo-
cytosed CD8-CIMPR and golgin97 using ImageJ. For analysis of 
tubulation, tubules were identified as thin, elongated structures with 
a length at least 1.5× greater than their width, as determined by 
eye. Tubule lengths were recorded by tracing a line over the tubule 
(or the maximum tubule length for live-cell movies, for which the 
movie was paused at the frame in which a tubule was at its maxi-
mum length and a line was traced along it) with the Freehand line 
tool in ImageJ and then counted and measured using the Measure 
command. The average length of tubule per cell was then calcu-
lated using Excel (Microsoft, Redmond, WA). Means were compared 
using the one-way analysis of variance (ANOVA) test or Student’s t 
test, or using a Mann–Whitney test or a Kruskal–Wallis test if data 
were not normally distributed, as indicated, with GraphPad Prism 6 
(GraphPad Software, La Jolla, CA). The SD, SEM, and graphs were 
calculated or generated using GraphPad Prism 6. Adjusted p values 
calculated using Dunnett’s adjustments are reported, where multi-
ple comparisons have been conducted using one-way ANOVA. Stu-
dent’s t tests were conducted using Welch’s correction to assume 
that samples did not have equal variances.
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